NCT07474207

Brief Summary

The goal of this clinical trial is to address the gap between clinical treatment and adolescents' lived social environments by developing and testing a novel, interactive intervention-SIM-AiR-that directly targets social risk and protective factors. By helping youth visually and cognitively process their social identities and networks, SIM-AiR seeks to support more enduring recovery outcomes in adolescents (12-19 years old) with alcohol use disorder (AUD). The specific aims of this study protocol are to pilot the SIM-AiR intervention module and collect participant acceptability feedback and preliminary outcomes. The main questions it aims to answer are: What is the acceptability of the SIM-AiR treatment module from the perspective of participants? Do participants' acceptability ratings of the SIM-AiR treatment module vary by personal and/or social network characteristics? Clinicians will implement the SIM-AiR with an adolescent client. Clinicians will provide feedback to the study team on their experience to support future implementation. Participants will complete the SIM-AiR module during a treatment session with their clinician and participate in data collection with study staff (e.g., surveys, interviews) following the treatment session.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
24mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

March 6, 2026

Last Update Submit

March 13, 2026

Conditions

Keywords

Social networkSocial Identity MappingAlcohol use disorderTreatmentAddiction recoveryAdolescents

Outcome Measures

Primary Outcomes (5)

  • SIM-AiR Acceptability (Treatment satisfaction)

    The acceptability of the SIM-AiR module from adolescents' perspectives will be assessed using the validated Treatment Satisfaction scale. Participants will answer 5 questions on a likert scale of (1) 'Strongly disagree' to (5) 'Strongly agree'. Scores range from 5-25, with higher scores indicating a greater satisfaction with the SIM-AiR module.

    Baseline

  • SIM-AiR Acceptability (Adolescent Treatment Engagement: Counseling Rapport sub scale)

    The acceptability of the SIM-AiR module from adolescents' perspectives will be assessed using the validated Counseling Rapport sub scale of the TCU Adolescent Engagement Form. Participants will answer 11 questions on a likert scale of (1) 'Strongly disagree' to (5) 'Strongly agree'. Scores range from 10-50, with higher scores indicating a greater rapport with the treatment counselor.

    Baseline

  • SIM-AiR Acceptability (Acceptability of Intervention Measure)

    The acceptability of the SIM-AiR module from clinicians' perspectives will be assessed using the validated Acceptability of Intervention Measure (AIM). Clinicians will answer 4 questions on a likert scale of (1) 'Completely disagree' to (5) 'Completely agree'. Scores range from 4-20, with higher scores indicating a greater perceived acceptability of the SIM-AiR as a treatment module.

    Baseline

  • SIM-AiR Appropriateness (Intervention Appropriateness Measure)

    The appropriateness of the SIM-AiR module from clinicians' perspectives will be assessed using the validated Intervention Appropriateness Measure (IAM). Clinicians will answer 4 questions on a likert scale of (1) 'Completely disagree' to (5) 'Completely agree'. Scores range from 4-20, with higher scores indicating a greater perceived appropriateness of the SIM-AiR as a treatment module.

    Baseline

  • SIM-AiR Feasibility (Feasibility of Intervention Measure)

    The feasibility of the SIM-AiR module from clinicians' perspectives will be assessed using the validated Feasibility of Intervention Measure (FIM). Clinicians will answer 4 questions on a likert scale of (1) 'Completely disagree' to (5) 'Completely agree'. Scores range from 4-20, with higher scores indicating a greater perceived feasibility of the SIM-AiR as a treatment module.

    Baseline

Study Arms (1)

SIM-AiR

EXPERIMENTAL

As this is a single arm study, all participants will receive the SIM-AiR treatment module.

Behavioral: SIM-AiR

Interventions

SIM-AiRBEHAVIORAL

The clinician would engage the adolescent participant in the activity of social identity mapping (SIM) and use that to have a discussion, using motivational interviewing principles, about their social networks and social influences (supports, barriers) to treatment and recovery. The SIM process involves posing a series of questions to produce a visual map of the individual within their social network using paper, markers, and stickers. As this is a pilot study, this will be done once.

Also known as: SIM, Social Identity Mapping
SIM-AiR

Eligibility Criteria

Age12 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Eligible participants are adolescents (ages 12-19) enrolled as outpatient clients at an addiction treatment facility.
  • Meet criteria for alcohol use disorder (mild to severe) as per the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V).
  • Be able to speak, read, and understand English.

You may not qualify if:

  • Refusal to give informed consent, or if under 18 years old, do not have a parent willing for them to consent to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Recovery Research Institute; National Center on Youth Prevention, Treatment, & Recovery; Harvard Medical School

Boston, Massachusetts, 02114, United States

Location

Related Publications (3)

  • Jurinsky J, Cowie K, Blyth S, Hennessy EA. "A lot better than it used to be": A qualitative study of adolescents' dynamic social recovery capital. Addict Res Theory. 2023;31(2):77-83. doi: 10.1080/16066359.2022.2114076. Epub 2022 Aug 29.

    PMID: 37008756BACKGROUND
  • Hennessy EA, Jurinsky J, Cowie K, Pietrzak AZ, Blyth S, Krasnoff P, Best D, Litt M, Johnson BT, Kelly JF. Visualizing the Influence of Social Networks on Recovery: A Mixed-Methods Social Identity Mapping Study with Recovering Adolescents. Subst Use Misuse. 2024;59(9):1405-1415. doi: 10.1080/10826084.2024.2352618. Epub 2024 May 13.

    PMID: 38738809BACKGROUND
  • Blyth SH, Pietrzak A, Rodriguez WA, Litt MD, Kelly JF, Hennessy EA. A Qualitative Examination of Addiction Disclosure and Stigma among Recovering Adolescents. Addict Res Theory. 2025;33(4):286-293. doi: 10.1080/16066359.2024.2431598. Epub 2024 Nov 28.

    PMID: 40785814BACKGROUND

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Emily A Hennessy, PhD

    Recovery Research Institute; National Center on Youth Prevention, Treatment, & Recovery; Harvard Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 6, 2026

First Posted

March 16, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

August 1, 2028

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Given the size of the trial and the proposed participant sample, the potential risks to breaches of confidentiality are too great.

Locations